Westchester Capital Management (New York)’s DermTech, Inc. Common Stock DMTK Stock Holding History

Westchester Capital Management (New York)’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-693,580	Closed	-$14.2M	–	124
2018 Q4	$14.2M	Hold	693,580	–	–	0.62%	30
2018 Q3	$14M	Buy	693,580 +425,000	+158%	+$8.54M	0.53%	30
2018 Q2	$5.35M	Buy	268,580 +172,730	+180%	+$3.43M	0.21%	47
2018 Q1	$1.89M	Buy	+95,850	New	+$1.88M	0.07%	68

Other funds holding DMTK

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Westchester Capital Management (New York)'s DMTK Position: Q1 2019 in Review

Westchester Capital Management (New York) sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2019, closing a stake of 693,580 shares — an estimated $14.2M sold.

Westchester Capital Management (New York) first reported a position in DMTK in Q1 2018 and held it in 4 quarters. The position peaked at $14.2M in Q4 2018. 5 funds tracked by Wall St. Rank hold DMTK as of Q1 2019.

Westchester Capital Management (New York) reported no remaining DermTech, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Westchester Capital Management (New York) sold 693,580 DermTech, Inc. Common Stock shares in Q1 2019, an estimated $14.2M.
Westchester Capital Management (New York) first reported a position in DermTech, Inc. Common Stock in Q1 2018 and held it in 4 quarters.
Westchester Capital Management (New York)'s DermTech, Inc. Common Stock position peaked at $14.2M in Q4 2018.
5 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2019.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2019, filed 15 May 2019.